Glenmark Specialty S.A. and Lotus International Pte. Ltd. enter into Exclusive Licensing Agreement for commercializing Ryaltris (TM) Nasal Spray in Singapore, Hong Kong and Vietnam
Under the terms of the agreement, Glenmark will be responsible for the manufacture and supply of Ryaltris™, while Lotus International Pte. Ltd. will be responsible for the commercialization of Ryaltris™ (subject to receipt of regulatory approvals) across these markets. Glenmark will receive an upfront payment as well as regulatory...
Researchers probe the potential impact of medicinal cannabis on Long COVID symptoms
Long COVID refers to the chronic symptoms of COVID-19, which include chronic pain, sleep disturbances and fatigue The Bod Australia study, in partnership with UK researchers, has the potential to pave the way for management or treatment options for the estimated one in 10 people with chronic symptoms following COVID infection Bod Australia's medicinal cannabis...
Nippon Express (Belgium) Acquires GDP Certification for Facility in Brussels Airport’s Cargo Area
TOKYO, Jan. 20, 2022 /PRNewswire/ -- Nippon Express (Belgium) N.V./S.A. (hereinafter "NX Belgium"), a company of the Nippon Express Holdings, Inc. Group, has obtained Good Distribution Practice (GDP) certification, effective December 21, 2021, for air and ground forwarding operations, inclusive of inventory control, at a facility in the cargo area of Brussels Airport, evidencing its compliance with GDP...
Shanghai Administration of Sports releases 2021 annual report and work plan for 2022
SHANGHAI, Jan. 20, 2022 /PRNewswire/ -- Shanghai Administration of Sports has released its 2021 annual report and work plan for 2022 here recently. Shanghai River Regatta along the Suzhou River, Oct. 23-24, 2021 According to the report, in the Tokyo Olympic Games, the number of Shanghai athletes admitted in the Olympic Games...
LifeWave Adds 2X Ironman Champion Jason Fowler as Spokesperson
Fowler's inspiring story of dedication and victory is enhanced by patented technology SAN DIEGO, Jan. 20, 2022 /PRNewswire/ -- Prominent health technology company, LifeWave, Inc., is pleased to announce the hiring of its newest spokesperson, elite athlete Jason Fowler. In his role as spokesperson for LifeWave, the New England native will...
Award: Boehringer Ingelheim is Global Top Employer 2022
Boehringer Ingelheim advances to one of eleven global top employers worldwide This is the second consecutive year for the global certification, and the third consecutive year for the certification in Vietnam High scores in values, ethics and integrity serve as a driver for a strong corporate innovation culture HO CHI MINH CITY, Vietnam, Jan....
Australia Therapeutic Goods Administration (TGA) Grants Provisional Registration for Novavax COVID-19 Vaccine
Nuvaxovid™ is the first protein-based COVID-19 vaccine to receive approval for provisional registration in Australia GAITHERSBURG, Md., Jan. 20, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that Australia's Therapeutic Goods Administration (TGA) has granted approval for...
“JEWISH NOBEL” AWARDED TO PFIZER CEO ALBERT BOURLA
Genesis Prize Chairman highlights immense role of Jewish scientists and doctors in combatting the pandemic: "A very proud moment for the entire Jewish community" JERUSALEM, Jan. 20, 2022 /PRNewswire/ -- Today, The Genesis Prize Foundation announced Dr. Albert Bourla, Chairman and CEO of Pfizer, as the 2022 Genesis Prize Laureate. Dr. Bourla received the...
Neurophth Therapeutics Receives IND Clearance to Initiate Clinical Trial for China AAV-ND4 Gene Therapy NR082 in Leber Hereditary Optic Neuropathy
WUHAN, China and SAN DIEGO, Jan. 19, 2022 /PRNewswire/ -- Neurophth Therapeutics, Inc., (hereinafter referred to as "Neurophth"), today announced receiving the U.S. Food and Drug Administration (FDA) clearance of its investigational new drug (IND) application on the in-vivo gene replacement therapy NR082 (rAAV2-ND4), the first of its kind in China, for...
Operation Smile Announces 10-Year Commitment to Transform the Lives of 1 Million Patients Globally
Marking its 40th Anniversary Year, Global Non-Profit Scales Up Commitments to Transform Local Health Systems, Address the Most Critical Needs in Global Cleft Care VIRGINIA BEACH, Va., Jan. 19, 2022 /PRNewswire/ -- Global nonprofit Operation Smile announced a 10-year commitment today to increase access to care for 1 million patients who...
